JIXING is a leading biotechnology company committed to bringing innovative science and medicines to underserved patients in China.
The JIXING advantage
Differentiated China-based biotech with a patient-centric approach dedicated to improving outcomes in Cardiovascular and Ophthalmology.
A growing pipeline of high-quality, de-risked assets based on clinical results of our partners and with significant market potential in Greater China.
Founded and backed by RTW Investments, a leading global, full life-cycle healthcare investment firm and a proven company builder
World class team
A world-class team with diversified background in multinational and domestic public companies and strong capabilities in clinical execution, regulatory and commercialization